{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:01Z","timestamp":1786119661302,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/gme.0b013e3182027963","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T03:07:32Z","timestamp":1298430452000},"page":"621-624","source":"Crossref","is-referenced-by-count":2,"title":["Breast cancer risk assessment"],"prefix":"10.1097","volume":"18","author":[{"given":"Roger P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Muram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jnci\/86.8.600","article-title":"Validation of the Gail et al. model for predicting individual breast cancer risk.","volume":"86","author":"Spiegelman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence.","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","article-title":"Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.","volume":"31","author":"Sabatino","year":"2007","journal-title":"Cancer Detect Prev"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R8-7-20210211","first-page":"835","article-title":"Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: Number 39, October 2002. Selective estrogen receptor modulators.","volume":"100","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.2001.6160","article-title":"Breast cancer risk assessment in indigent women at a public hospital.","volume":"81","author":"Abu-Rustum","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3122\/jabfm.2009.03.080153","article-title":"Diffusion of breast cancer risk assessment in primary care.","volume":"22","author":"Guerra","year":"2009","journal-title":"J Am Board Fam Med"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9149(01)01685-X","article-title":"Design and methods of the Raloxifene Use for the Heart (RUTH) study.","volume":"88","author":"Mosca","year":"2001","journal-title":"Am J Cardiol"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/djm224","article-title":"Predicting risk of breast cancer in postmenopausal women by hormone receptor status.","volume":"99","author":"Chlebowski","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2407-9-326","article-title":"Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain).","volume":"9","author":"Rue","year":"2009","journal-title":"BMC Cancer"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ejca.2009.03.022","article-title":"How effective are breast cancer screening programmes by mammography? Review of the current evidence.","volume":"45","author":"Schopper","year":"2009","journal-title":"Eur J Cancer"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics.","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e3182027963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:51:45Z","timestamp":1786042305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201106000-00007"}},"subtitle":["positive predictive value of family history as a predictor of risk"],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3182027963","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}